Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029174955> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2029174955 endingPage "242" @default.
- W2029174955 startingPage "241" @default.
- W2029174955 abstract "Obesity-induced inflammation causes cellular resistance to both insulin and leptin. In this issue, Brüning and colleagues (Kleinridders et al., 2009Kleinridders A. Schenten D. Könner C.A. Belgardt B.F. Mauer J. Okamura T. Wunderlich F.T. Medzhitov R. Brüning J.C. Cell Metab. 2009; 10 (this issue): 249-259Abstract Full Text Full Text PDF PubMed Scopus (339) Google Scholar) add to growing evidence that this response occurs in the hypothalamus, as well as in peripheral tissues, which helps to explain how high-fat feeding induces a gradual increase in defended body weight. Obesity-induced inflammation causes cellular resistance to both insulin and leptin. In this issue, Brüning and colleagues (Kleinridders et al., 2009Kleinridders A. Schenten D. Könner C.A. Belgardt B.F. Mauer J. Okamura T. Wunderlich F.T. Medzhitov R. Brüning J.C. Cell Metab. 2009; 10 (this issue): 249-259Abstract Full Text Full Text PDF PubMed Scopus (339) Google Scholar) add to growing evidence that this response occurs in the hypothalamus, as well as in peripheral tissues, which helps to explain how high-fat feeding induces a gradual increase in defended body weight. Prior to the discovery of the adipocyte hormone leptin, obesity was thought to result more from a lack of will power than from an underlying biological disorder. Now, 15 years after leptin's discovery, a much different picture of how obesity occurs is beginning to emerge. At its heart is evidence that consuming a high-fat (HF) diet induces inflammation in key neuronal systems that govern energy homeostasis, an effect that increases the defended level of body weight. The paper by Brüning and colleagues in the current issue of Cell Metabolism (Kleinridders et al., 2009Kleinridders A. Schenten D. Könner C.A. Belgardt B.F. Mauer J. Okamura T. Wunderlich F.T. Medzhitov R. Brüning J.C. Cell Metab. 2009; 10 (this issue): 249-259Abstract Full Text Full Text PDF PubMed Scopus (339) Google Scholar) advances the field by demonstrating that, in mice, the ability of a HF diet to induce obesity and its associated metabolic derangements depends upon neuronal expression of MyD88, a key intracellular mediator of inflammatory signaling. The link between HF feeding, hypothalamic inflammation, and the control of body weight has its roots in the study of how insulin resistance develops when tissues are exposed to a supply of nutrients that exceeds their energy requirements. In muscle, liver, adipose tissue, and the vasculature, sustained exposure to nutrient excess induces cellular inflammation via multiple, convergent mechanisms (Hotamisligil, 2006Hotamisligil G.S. Nature. 2006; 444: 860-867Crossref PubMed Scopus (5602) Google Scholar, Kim et al., 2007Kim F. Pham M. Luttrel I. Bannerman D.D. Tupper J. Thaler J.P. Hawn T.R. Raines E.W. Schwartz M.W. Circ. Res. 2007; 100: 1589-1596Crossref PubMed Scopus (432) Google Scholar). In addition to the recruitment and activation of immune cells in adipose tissue of obese individuals, nutrient excess can also induce inflammation via cell-autonomous mechanisms (Hotamisligil, 2006Hotamisligil G.S. Nature. 2006; 444: 860-867Crossref PubMed Scopus (5602) Google Scholar). For example, exposure of many cell types (e.g., adipocytes, macrophages, and endothelial cells) to saturated fatty acids such as palmitate increases signaling via toll-like receptor 4 (TLR4), thereby activating the proinflammatory IKKβ-NFκB transcriptional pathway (Kim et al., 2007Kim F. Pham M. Luttrel I. Bannerman D.D. Tupper J. Thaler J.P. Hawn T.R. Raines E.W. Schwartz M.W. Circ. Res. 2007; 100: 1589-1596Crossref PubMed Scopus (432) Google Scholar). Nutrient excess can also trigger cellular inflammation by raising intracellular levels of reactive oxygen species, by causing endoplasmic reticulum stress, and through still other mechanisms. This inflammatory response, in turn, causes insulin resistance via inhibition of the IRS-PI3K signal transduction pathway downstream of the insulin receptor (a key mediator of insulin's metabolic effects) and by induction of suppressor of cytokine-3 signaling (SOCS3), which blocks insulin receptor signaling (Hotamisligil, 2006Hotamisligil G.S. Nature. 2006; 444: 860-867Crossref PubMed Scopus (5602) Google Scholar, Kim et al., 2007Kim F. Pham M. Luttrel I. Bannerman D.D. Tupper J. Thaler J.P. Hawn T.R. Raines E.W. Schwartz M.W. Circ. Res. 2007; 100: 1589-1596Crossref PubMed Scopus (432) Google Scholar). Importantly, these inflammation-induced responses block signaling by leptin as well as by insulin. Given the diversity of tissues affected by nutrient excess, it is perhaps unsurprising that the hypothalamus is also susceptible (De Souza et al., 2005De Souza C.T. Araujo E.P. Bordin S. Ashimine R. Zollner R.L. Boschero A.C. Saad M.J. Velloso L.A. Endocrinology. 2005; 146: 4192-4199Crossref PubMed Scopus (708) Google Scholar). Unlike inflammation in peripheral tissues, however, this hypothalamic response has the potential to cause obesity, rather than simply being its consequence. This is because leptin and insulin are crucial signals that convey “adiposity negative feedback” information to the hypothalamus regarding the amount of body fuel stored in the form of fat. When input from these hormones is reduced, therefore, the hypothalamus perceives this as evidence of reduced body fat and triggers an adaptive increase of food intake relative to energy expenditure that favors weight gain. Indeed, the same phenomenon helps to explain why it is so hard to keep off weight lost through calorically restricted diets. Accordingly, when inflammation-induced impairment of insulin and leptin signal transduction occurs in key hypothalamic neurons, this elicits a state of positive energy balance until body fat stores, along with plasma leptin and insulin concentrations, rise sufficiently to overcome the resistance. This picture—increased plasma insulin and leptin levels, combined with the defense of an elevated level of body weight—is characteristic of common obesity. The concept that common forms of obesity might arise from hypothalamic leptin resistance is not new, having first been reported in rodent models of diet-induced obesity (DIO) nearly a decade ago (El-Haschimi et al., 2000El-Haschimi K. Pierroz D.D. Hileman S.M. Bjørbaek C. Flier J.S. J. Clin. Invest. 2000; 105: 1827-1832Crossref PubMed Scopus (684) Google Scholar). But broad acceptance of acquired leptin resistance as a cause of common obesity has been hampered both by a lack of insight into how it occurs and by uncertainty about whether it is simply a consequence of obesity and not a cause. By offering an answer to the first question, the emerging role of hypothalamic inflammation is beginning to clarify the second (Wisse et al., 2007Wisse B.E. Kim F. Schwartz M.W. Science. 2007; 318: 928-929Crossref PubMed Scopus (104) Google Scholar). Last year, Cai and colleagues (Zhang et al., 2008Zhang X. Zhang G. Zhang H. Karin M. Bai H. Cai D. Cell. 2008; 135: 61-73Abstract Full Text Full Text PDF PubMed Scopus (948) Google Scholar) reported that mice with neuron-specific deletion of IKKβ are resistant to the effect of high-fat (HF) feeding to cause both obesity and central insulin and leptin resistance, whereas interventions that predispose to neuronal inflammation favor excess weight gain. Similarly, Niswender and colleagues (Posey et al., 2008Posey K.A. Clegg D.J. Printz R.L. Byun J. Morton G.J. Vivekanandan-Giri A. Pennathur S. Baskin D.G. Heinecke J.W. Woods S.C. et al.Am. J. Physiol. Endocrinol. Metab. 2008; 296: E1003-E1012Crossref PubMed Scopus (392) Google Scholar) showed that central administration of an IKKβ inhibitor increases hypothalamic insulin sensitivity while reducing food intake and body weight in rats on a HF diet; in rats fed standard chow (that do not have hypothalamic inflammation), this intervention was without effect. These findings imply a role for leptin and insulin resistance induced by hypothalamic inflammation in the mechanism whereby HF feeding causes obesity. The paper by Brüning and colleagues (Kleinridders et al., 2009Kleinridders A. Schenten D. Könner C.A. Belgardt B.F. Mauer J. Okamura T. Wunderlich F.T. Medzhitov R. Brüning J.C. Cell Metab. 2009; 10 (this issue): 249-259Abstract Full Text Full Text PDF PubMed Scopus (339) Google Scholar) extends this work by demonstrating that brain-specific deletion of MyD88, an adaptor protein that couples TLR4 and IL-1 receptor signaling to IKKβ activation, attenuates the deleterious cascade of events initiated by HF: hypothalamic inflammation, leptin resistance, obesity, and peripheral metabolic dysfunction. Increased leptin sensitivity in mice with brain-specific MyD88 deletion was detected early in the course of HF feeding, prior to any difference in body weight from control animals. By suggesting that diminished hypothalamic inflammation and leptin resistance protects against obesity rather than that protection from obesity reduces hypothalamic inflammation and leptin resistance, this observation addresses what has been a troubling chicken-and-egg problem. Moreover, the authors report that mice with brain-specific MyD88 deletion are protected from hypothalamic inflammation and leptin resistance induced by acute central application of palmitate, as well as from impairment of peripheral glucose metabolism induced by either centrally administered palmitate or by consuming a HF diet. Furthermore, they show that, although HF feeding in normal mice induces hypothalamic inflammation via the JNK as well as the IKKβ-NFκB pathway, only the latter seems to be required for the associated hypothalamic leptin resistance and weight gain (because mice with brain-specific JNK knockout are not protected against these responses). Many compelling questions remain to be addressed. Which hypothalamic cell type triggers inflammation in response to HF feeding? In addition to neurons, microglia (the resident macrophage of the brain) can also induce inflammation, and macrophages in peripheral tissues clearly contribute to obesity-associated inflammatory responses. Because microglia dynamically survey adjacent neurons for evidence of inflammation and can act rapidly to suppress this response, however, the question of whether they might increase or decrease neuronal inflammation during HF feeding awaits further study (see Figure 1). Do genetic factors that affect obesity susceptibility act by modifying hypothalamic inflammation? Does exercise training blunt the effect of HF feeding to induce inflammation in hypothalamus (and thereby favor defense of a lower body weight), as it does in peripheral tissues? Is diet composition critical, or is an excess of nutrients, per se, sufficient to trigger these responses irrespectively of what is eaten? Lastly, hypothalamic inflammation is also implicated in anorexia and weight loss induced by acute, systemic illness (e.g., bacterial sepsis). How can brain inflammation induce negative energy balance in some conditions while predisposing to obesity in others? Answers to these questions may help to inform new approaches to the prevention and treatment of obesity. MyD88 Signaling in the CNS Is Required for Development of Fatty Acid-Induced Leptin Resistance and Diet-Induced ObesityKleinridders et al.Cell MetabolismOctober 07, 2009In BriefObesity-associated activation of inflammatory pathways represents a key step in the development of insulin resistance in peripheral organs, partially via activation of TLR4 signaling by fatty acids. Here, we demonstrate that palmitate acting in the central nervous system (CNS) inhibits leptin-induced anorexia and Stat3 activation. To determine the functional significance of TLR signaling in the CNS in the development of leptin resistance and diet-induced obesity in vivo, we have characterized mice deficient for the TLR adaptor molecule MyD88 in the CNS (MyD88ΔCNS). Full-Text PDF Open Archive" @default.
- W2029174955 created "2016-06-24" @default.
- W2029174955 creator A5053926256 @default.
- W2029174955 creator A5063866141 @default.
- W2029174955 date "2009-10-01" @default.
- W2029174955 modified "2023-10-11" @default.
- W2029174955 title "Does Hypothalamic Inflammation Cause Obesity?" @default.
- W2029174955 cites W1669871566 @default.
- W2029174955 cites W1964562779 @default.
- W2029174955 cites W1979598489 @default.
- W2029174955 cites W2000054651 @default.
- W2029174955 cites W2017712441 @default.
- W2029174955 cites W2075792687 @default.
- W2029174955 cites W2077033935 @default.
- W2029174955 cites W2088666203 @default.
- W2029174955 doi "https://doi.org/10.1016/j.cmet.2009.09.003" @default.
- W2029174955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19808014" @default.
- W2029174955 hasPublicationYear "2009" @default.
- W2029174955 type Work @default.
- W2029174955 sameAs 2029174955 @default.
- W2029174955 citedByCount "56" @default.
- W2029174955 countsByYear W20291749552012 @default.
- W2029174955 countsByYear W20291749552013 @default.
- W2029174955 countsByYear W20291749552014 @default.
- W2029174955 countsByYear W20291749552015 @default.
- W2029174955 countsByYear W20291749552016 @default.
- W2029174955 countsByYear W20291749552017 @default.
- W2029174955 countsByYear W20291749552018 @default.
- W2029174955 countsByYear W20291749552019 @default.
- W2029174955 countsByYear W20291749552020 @default.
- W2029174955 countsByYear W20291749552021 @default.
- W2029174955 countsByYear W20291749552022 @default.
- W2029174955 countsByYear W20291749552023 @default.
- W2029174955 crossrefType "journal-article" @default.
- W2029174955 hasAuthorship W2029174955A5053926256 @default.
- W2029174955 hasAuthorship W2029174955A5063866141 @default.
- W2029174955 hasBestOaLocation W20291749551 @default.
- W2029174955 hasConcept C126322002 @default.
- W2029174955 hasConcept C2776914184 @default.
- W2029174955 hasConcept C511355011 @default.
- W2029174955 hasConcept C60644358 @default.
- W2029174955 hasConcept C71924100 @default.
- W2029174955 hasConcept C86803240 @default.
- W2029174955 hasConceptScore W2029174955C126322002 @default.
- W2029174955 hasConceptScore W2029174955C2776914184 @default.
- W2029174955 hasConceptScore W2029174955C511355011 @default.
- W2029174955 hasConceptScore W2029174955C60644358 @default.
- W2029174955 hasConceptScore W2029174955C71924100 @default.
- W2029174955 hasConceptScore W2029174955C86803240 @default.
- W2029174955 hasIssue "4" @default.
- W2029174955 hasLocation W20291749551 @default.
- W2029174955 hasLocation W20291749552 @default.
- W2029174955 hasOpenAccess W2029174955 @default.
- W2029174955 hasPrimaryLocation W20291749551 @default.
- W2029174955 hasRelatedWork W1977637999 @default.
- W2029174955 hasRelatedWork W1998569023 @default.
- W2029174955 hasRelatedWork W2018225634 @default.
- W2029174955 hasRelatedWork W2039434363 @default.
- W2029174955 hasRelatedWork W2042298174 @default.
- W2029174955 hasRelatedWork W2057374871 @default.
- W2029174955 hasRelatedWork W2094748025 @default.
- W2029174955 hasRelatedWork W2124554856 @default.
- W2029174955 hasRelatedWork W2417148651 @default.
- W2029174955 hasRelatedWork W4214871516 @default.
- W2029174955 hasVolume "10" @default.
- W2029174955 isParatext "false" @default.
- W2029174955 isRetracted "false" @default.
- W2029174955 magId "2029174955" @default.
- W2029174955 workType "article" @default.